trending Market Intelligence /marketintelligence/en/news-insights/trending/lH9QgyY_nSfDTwW-o2lgWw2 content esgSubNav
In This List

Microbot Medical closes $10M stock offering

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Microbot Medical closes $10M stock offering

Microbot Medical Inc. closed a registered direct offering of 3,750,000 common shares for gross proceeds of $10.1 million.

The company will use the proceeds for its ViRob and TipCAT technology platforms, potential partnerships, and acquisitions and general corporate and working capital purposes.

Ladenburg Thalmann & Co. Inc. acted as the lead placement agent, while Chardan acted as the co-placement agent of the offering.